D-0773-2026 Class I Ongoing

Recalled by Liebel-Flarsheim Company LLC — Raleigh, NC

FDA drug recall D-0773-2026 was initiated by Liebel-Flarsheim Company LLC on Jul 31, 2026 and is designated Class I. Reason for recall: Presence of Particulate Matter: comprising polyethylene and other plastic materials, stainless steel and glass. The recall status is ongoing. Affected quantity: 3,486 500mL-vials.

Recall details

Product Type
Drugs
Report Date
Aug 19, 2026
Initiation Date
Jul 31, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,486 500mL-vials

Product description

Optiray Imaging Bulk Package-350, Ioversol Injection 74%, 350 mg/mL Organically Bound Iodine, 500 mL Multiple-Dose Vial, Rx only, Sterile Solution, Manufactured by: Liebel-Flarsheim Company LLC, Raleigh, NC 27616, Made in USA, NDC 0019-1333-65.

Reason for recall

Presence of Particulate Matter: comprising polyethylene and other plastic materials, stainless steel and glass.

Distribution pattern

Distributed Nationwide in the US and Mexico.

Code information

Lot # 25ZF3670, Exp Date: May 31, 2027.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0773-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0773-2026. Report a data issue: hello@regdatalab.com.